Advanced Search
Title
Company
Description
Post a Job

Location:

Focus Search:

t rowe price
verily
computational scientist
laboratory associate
blood draw
computational biology
assay development
roche
quality specialist
clinical laboratory scientist
accessioning
rna
novartis
laboratory assistant
lesbian
polaris
gay
qms
bioinformatics
venture capital

Freenome

Biotechnology company in South San Francisco, California

Address:

279 E Grand Ave 5th Floor, South San Francisco, CA 94080
Freenome is an AI Genomics biotech company in south San Francisco. By using a simple blood test, we can help detect and treat cancer quickly and efficiently.
Active Date
  • Active Date
  • Relevance
All Jobs
  • All Jobs
  • Active
1,642 Jobs
Clinical Laboratory Assistant, Analytical Laboratory
FreenomeSouth San Francisco, CA
Our recent $270 Million Series C brings our financing to over $500 million from investors, including; Bain Capital, Perceptive Advisors, RA Capital, Polaris Partners, Andreessen Horowitz, funds and accounts advised by T. Rowe Price Associates, Inc., GV (formerly Google Ventures), Roche Venture Fund, Kaiser Permanente Ventures, American Cancer Society's BrightEdge Ventures, Data Collective Venture Capital, Novartis and Verily Life Sciences.
Full-time
Last updated 1 hour ago
Director of Computational Biology, Assay R&D
FreenomeSan Francisco, CA
Nurture and grow a computational scientist team, by mentoring existing staff and by recruiting and hiring new staff with skill sets and scientific development goals aligned with Freenome s needs and mission.Last updated 1 hour ago
Vice President, Laboratory Operations
FreenomeSan Francisco, CA
 Our recent $270 Million Series C brings our financing to over $500 million from investors, including; Bain Capital, Perceptive Advisors, RA Capital, Polaris Partners, Andreessen Horowitz, funds and accounts advised by T. Rowe Price Associates, Inc., GV (formerly Google Ventures), Roche Venture Fund, Kaiser Permanente Ventures, American Cancer Society's BrightEdge Ventures, Data Collective Venture Capital, Novartis and Verily Life Sciences.
Full-time
Last updated 1 hour ago
Quality Specialist/ Engineer ll
FreenomeSouth San Francisco, CA
Our recent $270 Million Series C brings our financing to over $500 million from investors, including; Bain Capital, Perceptive Advisors, RA Capital, Polaris Partners, Andreessen Horowitz, funds and accounts advised by T. Rowe Price Associates, Inc., GV (formerly Google Ventures), Roche Venture Fund, Kaiser Permanente Ventures, American Cancer Society's BrightEdge Ventures, Data Collective Venture Capital, Novartis and Verily Life Sciences.Last updated 1 hour ago
Senior / Research Associate, Preanalytical Development
FreenomeSouth San Francisco, CA
Our recent $270 Million Series C brings our financing to over $500 million from investors, including; Bain Capital, Perceptive Advisors, RA Capital, Polaris Partners, Andreessen Horowitz, funds and accounts advised by T. Rowe Price Associates, Inc., GV (formerly Google Ventures), Roche Venture Fund, Kaiser Permanente Ventures, American Cancer Society's BrightEdge Ventures, Data Collective Venture Capital, Novartis and Verily Life Sciences.
Full-time
Last updated 1 hour ago
Director, Real-World Data, Informatics
FreenomeSouth San Francisco, CA
Our recent $270 Million Series C brings our financing to over $500 million from investors, including; Bain Capital, Perceptive Advisors, RA Capital, Polaris Partners, Andreessen Horowitz, funds and accounts advised by T. Rowe Price Associates, Inc., GV (formerly Google Ventures), Roche Venture Fund, Kaiser Permanente Ventures, American Cancer Society's BrightEdge Ventures, Data Collective Venture Capital, Novartis and Verily Life Sciences.
Full-time
Last updated 1 hour ago
Senior Machine Learning Research Engineer
FreenomeSouth San Francisco, CA
Our recent $270 Million Series C brings our financing to over $500 million from investors, including; Bain Capital, Perceptive Advisors, RA Capital, Polaris Partners, Andreessen Horowitz, funds and accounts advised by T. Rowe Price Associates, Inc., GV (formerly Google Ventures), Roche Venture Fund, Kaiser Permanente Ventures, American Cancer Society’s BrightEdge Ventures, Data Collective Venture Capital, Novartis and Verily Life Sciences.Last updated 1 hour ago
Senior Human Resources Business Partner
FreenomeSan Francisco, CA
Autoimmune disorder, for example, lupus, fibromyalgia, rheumatoid arthritis, or HIV/AIDSLast updated 1 hour ago
Director, Market Development
Freenome HoldingsSouth San Francisco, CA
The company has raised $238 million from investors such as RA Capital, Polaris Partners, Perceptive Advisors, Andreessen Horowitz, funds and accounts advised by T. Rowe Price Associates, Inc., GV (formerly Google Ventures), Roche Venture Fund, Novartis, Kaiser Permanente Ventures, American Cancer Society s BrightEdge Ventures, Data Collective Venture Capital, Novartis, and Verily Life Sciences (formerly Google Life Sciences).Last updated 2 hours ago
Recruiter, Life Sciences - Contract
FreenomeSouth San Francisco, CA
Our recent $270 Million Series C brings our financing to over $500 million from investors, including; Bain Capital, Perceptive Advisors, RA Capital, Polaris Partners, Andreessen Horowitz, funds and accounts advised by T. Rowe Price Associates, Inc., GV (formerly Google Ventures), Roche Venture Fund, Kaiser Permanente Ventures, American Cancer Society's BrightEdge Ventures, Data Collective Venture Capital, Novartis and Verily Life Sciences.
Full-time
Last updated 2 hours ago
Director, Market Development, Real World Data
FreenomeSan Francisco, CA
Our recent $270 Million Series C brings our financing to over $500 million from investors, including; Bain Capital, Perceptive Advisors, RA Capital, Polaris Partners, Andreessen Horowitz, funds and accounts advised by T. Rowe Price Associates, Inc., GV (formerly Google Ventures), Roche Venture Fund, Kaiser Permanente Ventures, American Cancer Society’s BrightEdge Ventures, Data Collective Venture Capital, Novartis and Verily Life Sciences.Last updated 2 hours ago
Senior Clinical Data Scientist
FreenomeSan Francisco, CA
Our recent $270 Million Series C brings our financing to over $500 million from investors, including; Bain Capital, Perceptive Advisors, RA Capital, Polaris Partners, Andreessen Horowitz, funds and accounts advised by T. Rowe Price Associates, Inc., GV (formerly Google Ventures), Roche Venture Fund, Kaiser Permanente Ventures, American Cancer Society's BrightEdge Ventures, Data Collective Venture Capital, Novartis and Verily Life Sciences.Last updated 2 hours ago
12345Next »

Sponsored jobs: